The study of immune checkpoint inhibitors in chronic hepatitis B virus infection.
Li S, Li N, Yang S, Deng H, Li Y, Wang Y, Yang J, Lv J, Dong L, Yu G, Hou X, Wang G.
Li S, et al. Among authors: wang g, wang y.
Int Immunopharmacol. 2022 Aug;109:108842. doi: 10.1016/j.intimp.2022.108842. Epub 2022 May 12.
Int Immunopharmacol. 2022.
PMID: 35569306
Review.